138 related articles for article (PubMed ID: 15547704)
21. The role of caspase family protease, caspase-3 on cisplatin-induced apoptosis in cisplatin-resistant A431 cell line.
Mese H; Sasaki A; Nakayama S; Alcalde RE; Matsumura T
Cancer Chemother Pharmacol; 2000; 46(3):241-5. PubMed ID: 11021742
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic potential of Mdm2 inhibition in malignant germ cell tumours.
Bauer S; Mühlenberg T; Leahy M; Hoiczyk M; Gauler T; Schuler M; Looijenga L
Eur Urol; 2010 Apr; 57(4):679-87. PubMed ID: 19560254
[TBL] [Abstract][Full Text] [Related]
23. Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines.
Burger H; Nooter K; Boersma AW; Kortland CJ; Stoter G
Br J Cancer; 1998 May; 77(10):1562-7. PubMed ID: 9635829
[TBL] [Abstract][Full Text] [Related]
24. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
Mueller T; Voigt W; Simon H; Fruehauf A; Bulankin A; Grothey A; Schmoll HJ
Cancer Res; 2003 Jan; 63(2):513-21. PubMed ID: 12543810
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of FAK and IAPs by laminin during cisplatin-induced apoptosis in testicular germ cell tumors.
Andjilani M; Droz JP; Benahmed M; Tabone E
Int J Oncol; 2006 Feb; 28(2):535-42. PubMed ID: 16391810
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
[TBL] [Abstract][Full Text] [Related]
27. p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin.
Gutekunst M; Oren M; Weilbacher A; Dengler MA; Markwardt C; Thomale J; Aulitzky WE; van der Kuip H
PLoS One; 2011 Apr; 6(4):e19198. PubMed ID: 21532991
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals.
Song H; Wei M; Liu W; Shen S; Li J; Wang L
Histol Histopathol; 2018 Jan; 33(1):73-79. PubMed ID: 28287251
[TBL] [Abstract][Full Text] [Related]
29. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
Perry J; Powles T; Shamash J; Veerupillai A; McGrowder E; Noel E; Lu YJ; Oliver T; Joel S
Cancer Chemother Pharmacol; 2009 Oct; 64(5):925-33. PubMed ID: 19263053
[TBL] [Abstract][Full Text] [Related]
30. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
[TBL] [Abstract][Full Text] [Related]
31. The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma.
Stewart JH; Tran TL; Levi N; Tsai WS; Schrump DS; Nguyen DM
J Surg Res; 2007 Jul; 141(1):120-31. PubMed ID: 17574045
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity.
Schaffrath J; Schmoll HJ; Voigt W; Müller LP; Müller-Tidow C; Mueller T
PLoS One; 2017; 12(6):e0178930. PubMed ID: 28591197
[TBL] [Abstract][Full Text] [Related]
33. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance.
Brozovic A; Fritz G; Christmann M; Zisowsky J; Jaehde U; Osmak M; Kaina B
Int J Cancer; 2004 Dec; 112(6):974-85. PubMed ID: 15386344
[TBL] [Abstract][Full Text] [Related]
34. Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors.
Lengert AVH; Pereira LDNB; Cabral ERM; Gomes INF; Jesus LM; Gonçalves MFS; Rocha AOD; Tassinari TA; Silva LSD; Laus AC; Vidal DO; Pinto MT; Reis RM; Lopes LF
Front Biosci (Landmark Ed); 2022 Aug; 27(8):245. PubMed ID: 36042160
[TBL] [Abstract][Full Text] [Related]
35. Neferine and isoliensinine enhance 'intracellular uptake of cisplatin' and induce 'ROS-mediated apoptosis' in colorectal cancer cells - A comparative study.
Manogaran P; Beeraka NM; Huang CY; Vijaya Padma V
Food Chem Toxicol; 2019 Oct; 132():110652. PubMed ID: 31255669
[TBL] [Abstract][Full Text] [Related]
36. Strong apoptotic response of testis tumor cells following cisplatin treatment.
Köberle B; Usanova S; Piee-Staffa A; Heinicke U; Clauss P; Brozovic A; Kaina B
Int Urol Nephrol; 2024 Mar; 56(3):1007-1017. PubMed ID: 37891379
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin resistance induced in germ cell tumour cells is due to reduced susceptibility towards cell death but not to altered DNA damage induction or repair.
Fenske AE; Glaesener S; Bokemeyer C; Thomale J; Dahm-Daphi J; Honecker F; Dartsch DC
Cancer Lett; 2012 Nov; 324(2):171-8. PubMed ID: 22613583
[TBL] [Abstract][Full Text] [Related]
38. [Wogonoside reverses cisplatin resistance in SGC7901/cDDP cells through inhibition of PI3K/Akt/Nrf2/ARE signaling pathway].
Wang LJ; Wang SG; Deng TX
Sheng Li Xue Bao; 2018 Aug; 70(4):397-405. PubMed ID: 30112565
[TBL] [Abstract][Full Text] [Related]
39. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
[TBL] [Abstract][Full Text] [Related]
40. ERK/MAPK activation involves hypoxia-induced MGr1-Ag/37LRP expression and contributes to apoptosis resistance in gastric cancer.
Liu L; Zhang H; Sun L; Gao Y; Jin H; Liang S; Wang Y; Dong M; Shi Y; Li Z; Fan D
Int J Cancer; 2010 Aug; 127(4):820-9. PubMed ID: 19998339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
